Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
iBio, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
No intraday reading yet this session.
IBIO (iBio, Inc.) has 9 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
52 institutional managers report a position in iBio, Inc. worth $60.8M between them, filed on form 13F for the quarter ending 2026-06-30. 14 of them hold 80% of it, the largest being Affinity Asset Advisors, LLC at 11.54%.
27 more managers in the register
14 managers hold 80% of the $60.8M institutional base. The other 38 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Cormorant Asset Management, LLC, Affinity Asset Advisors, LLC, Silverarc Capital Management, LLC +2 more · 10.28% of IBIO, 7.51% of HLXC
via Affinity Asset Advisors, LLC, Frazier Life Sciences Management, L.P., Vestal Point Capital, LP +6 more · 11.54% of IBIO, 6.58% of LXEO
via Silverarc Capital Management, LLC, Woodline Partners LP, Affinity Asset Advisors, LLC +5 more · 10.13% of IBIO, 5.66% of SGMT
via Affinity Asset Advisors, LLC, Cormorant Asset Management, LLC, Silverarc Capital Management, LLC +2 more · 11.54% of IBIO, 4.97% of RACC
via Affinity Asset Advisors, LLC, Woodline Partners LP, Ikarian Capital, LLC +2 more · 11.54% of IBIO, 9.13% of PRQR
via Affinity Asset Advisors, LLC, Woodline Partners LP, ADAR1 Capital Management, LLC +3 more · 11.54% of IBIO, 9.80% of EQ
Managers holding a meaningful stake in IBIO also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.